DBV Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!

About DBVT

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. 

CEO
Daniel Tassé
CEODaniel Tassé
Employees
109
Employees109
Headquarters
Chatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded
2002
Founded2002
Employees
109
Employees109

DBVT Key Statistics

Market cap
292.58M
Market cap292.58M
Price-Earnings ratio
-1.87
Price-Earnings ratio-1.87
Dividend yield
—
Dividend yield—
Average volume
99.52K
Average volume99.52K
High today
$10.39
High today$10.39
Low today
$10.39
Low today$10.39
Open price
$11.00
Open price$11.00
Volume
1.41K
Volume1.41K
52 Week high
$12.78
52 Week high$12.78
52 Week low
$2.20
52 Week low$2.20
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.